FindTrial
Sign In

In Patients of Diabetic Peripheral Neuropathy, knowing effect of SGLT2 Inhibitors drug if able to improve nerve conduction studies

Effect Of SGLT2 Inhibitors On Nerve Conduction Studies In Diabetic Peripheral Neuropathy And Pattern Of Adverse Drug Reactions - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/107383
Enrollment
60
Registered
2026-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications

Interventions

Intervention1: SGLT2 inhibitor: one group receiving SGLT2 inhibitor medicine Control Intervention1: NON SGLT2 INHIBITOR RECEIVING GROUP: SECOND GROUP NOT RECEIVING SGLT2 INHIBITORS

Sponsors

Supriya Sahu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Clinically Diagnosed Patients with DPN 2.Cases of Adverse Drug Reactions due to SGLT2 Inhibitor in DPN patients 3.Patients providing informed consent

Exclusion criteria

Exclusion criteria: 1. Patients who did not give informed consent 2. Comorbid Conditions Patients with chronic kidney disease (CKD) 3. Critical Illness Includes malignancy, critically ill patients, and those with stroke or neurovascular complications 4. Neuromuscular Conditions Patients with myopathy ,neuromuscular diseases 5. Other Diabetes Type

Design outcomes

Primary

MeasureTime frame
1) To evaluate the effect of SGLT2 Inhibitor on Nerve Conduction Study in DPN subjects 2)To determine the incidence & pattern of ADRs with SGLT2 inhibitor Timepoint: Eighteen months—

Secondary

MeasureTime frame
To identify clinical predictors: age, sex, diabetes duration, co-morbidities influencing changes in nerve conduction in DPN Timepoint: Eighteen months—

Countries

India

Contacts

Public ContactSupriya Sahu

Jawaharlal Nehru Medical College

szrahman112@myamu.ac.in8266001772

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026